Intervention
Cediranib Maleate
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 5 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownOlaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung CancerNCT02899728 · 2018-03-30
TERMINATEDA Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsNCT02498613 · 2016-08-31
ACTIVE_NOT_RECRUITINGGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsNCT01131234 · 2010-05-01
COMPLETEDCediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast CancerNCT01116648 · 2010-04-14
ACTIVE_NOT_RECRUITINGPemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural MesotheliomaNCT01064648 · 2010-03-15
ACTIVE_NOT_RECRUITINGCommon conditions
Triple-Negative Breast Carcinoma2Adult Anaplastic Astrocytoma1Adult Anaplastic Ependymoma1Adult Anaplastic Oligodendroglioma1Adult Brain Stem Glioma1Adult Giant Cell Glioblastoma1Adult Glioblastoma1Adult Gliosarcoma1Adult Mixed Glioma1Adult Solid Neoplasm1Advanced Malignant Solid Neoplasm1Epithelioid Mesothelioma1Extensive Stage Lung Small Cell Carcinoma1Fallopian Tube Carcinoma1Male Breast Carcinoma1Metastatic Lung Non-Small Cell Carcinoma1Metastatic Lung Small Cell Carcinoma1Metastatic Pancreatic Adenocarcinoma1Metastatic Triple-Negative Breast Carcinoma1Ovarian Endometrioid Adenocarcinoma1Ovarian High Grade Serous Adenocarcinoma1Ovarian Serous Adenocarcinoma1Ovarian Serous Surface Papillary Adenocarcinoma1Pancreatic Ductal Adenocarcinoma1Pleural Malignant Mesothelioma1
Leading sponsors
Trial status mix
ACTIVE_NOT_RECRUITING3
COMPLETED1
TERMINATED1
Phase mix
PHASE24
PHASE13
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.